HIGHLIGHTS
- who: Ivyspring et al. from the Department of Medical Biophysics, University of Toronto, Canada have published the Article: Theranostics 2023, Vol. 13, Issue, in the Journal: (JOURNAL)
- what: In oncology this approach has demonstrated tumor growth inhibition and profound synergistic antitumor effects when combined with traditional platforms of chemo- radiation- and immune-therapies. As the radiosensitization work was conducted at lower pressures (500-750 kPa) and with higher MB doses, it is reasonable to consider that different mechanisms can be responsible for vascular disruption, depending on the exposure conditions.
- how: Collectively these data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.